Catalog Number JHJR071502J |
Device Problem
Complete Blockage (1094)
|
Patient Problems
Aneurysm (1708); Occlusion (1984)
|
Event Date 08/19/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
A review of the manufacturing records indicated the device met pre-release specifications.The device was not returned.Consequently, a direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.
|
|
Event Description
|
The following was reported to gore; on (b)(6) 2019, the patient underwent endovascular repair.The gore® viabahn® endoprosthesis was implanted in the celiac artery as a chimney device.The procedure was completed without any complications.The same day (6 hours later), the patient complained of abdominal pain.It was reported that the acidosis level was increased.Ct imaging showed an occlusion of the gore® viabahn® endoprosthesis in the celiac artery.Thrombus aspiration and ballooning were performed to treat the occlusion.Urokinase was then administrated, and the abdominal pain was resolved.Heparin and dual antiplatelet therapy (dapt) were also administrated.The acidosis level returned to a normal level.The patient tolerated the procedure.
|
|
Manufacturer Narrative
|
Corrected data: b5 describe event or problem.
|
|
Event Description
|
The following was reported to gore; on (b)(6), 2019, the patient underwent endovascular repair.The gore® viabahn® endoprosthesis was implanted in the celiac artery as a chimney device.The procedure was completed without any complications.The same day (6 hours later), the patient complained of abdominal pain.It was reported that the acidosis level was increased.Ct imaging showed an occlusion of the gore® viabahn® endoprosthesis and slightly compressed in the celiac artery.Thrombus aspiration and ballooning were performed to treat the occlusion.Urokinase was then administrated, and the abdominal pain was resolved.Heparin and dual antiplatelet therapy (dapt) were also administrated.The acidosis level returned to a normal level.The patient tolerated the procedure.
|
|
Manufacturer Narrative
|
Corrected data: h6 patient code 1.
|
|
Search Alerts/Recalls
|